Drugs / Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells

Follow last change May 2024 re-read 3 minutes ago

Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells

Developed for: brain cancer · childhood malignant neoplasm
Investigated by: CureSearch · Nationwide Children's Hospital · Rally Foundation · Sabine Mueller, MD, PhD · Tommy Strong Foundation · Washington University School of Medicine

today NCT05887882 · Ph 1

2025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT05887882	May 2024 → Dec 2027	brain cancer, childhood malignant neoplasm	Sabine Mueller, MD, PhD	Suspended	No outcome recorded Stop: Enrollment

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05887882 ↗
Action	Deplete	“Natural killer (NK) cells are immune cells that recognize and get rid of abnormal cells in the body, including tumor cells and cells infected by viruses.” NCT05887882 ↗
Modality	Cell therapy	“ex vivo expanded natural killer cells” NCT05887882 ↗
Route	Other	“administered intra-tumoral via an Ommaya reservoir” NCT05887882 ↗